Trial Profile
A Randomized, Balanced, Single Dose, Two-treatment (Fed vs. Fasting), Two-period, Two-sequence, Crossover Study to Evaluate the Effects of Food on the Bioavailability of 60 mg ER Torsemide Tablet in Healthy Human Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2018
Price :
$35
*
At a glance
- Drugs Torasemide (Primary)
- Indications Oedema
- Focus Pharmacokinetics
- Sponsors Sarfez Pharmaceuticals
- 17 Apr 2018 Status changed from not yet recruiting to completed.
- 15 Jul 2017 New trial record